insights into the role of novel btkis in the treatment landscape of r/r cll
Published 3 weeks ago • 55 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
2:34
sequencing of therapies in patients with r/r cll
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
29:16
szpiczak plazmocytowy – nowości: iii i kolejne linie leczenia
-
5:15
day in the life - heamatology / research - prof john rasko
-
2:23
understanding parkinson's disease
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:18
updates in the treatment of r/r lbcl: promising novel agents in the pipeline
-
3:00
five-year follow-up of the captivate trial: ibrutinib retreatment in patients with cll
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:00
insights into the future of the cll treatment landscape
-
2:02
recent advances in all treatment
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
0:50
management of variant acute promyelocytic leukemia
-
1:09
cll treatment: discussing new data from the last 3 years
-
1:39
next questions in the treatment and management of mpns